MELFION with Meloxicam as active ingredient is available in Tablet 15 mg.
MELFION is indicated for:
Short term symptomatic treatment of acute exacerbation osteoarthritis.
Long term symptomatic treatment of rheumatoid arthritis (chronic polyarthritis).
Osteoarthritis : 7.5 mg daily. If necessary, the dose may be increased to 15 mg/daily.
Rheumatoid arthritis : 15 mg daily. The dose may be reduced to 7.5 mg daily according to therapeutic response.
In patients with increased risk of adverse reactions: initial dose 7.5 mg daily.
In dialysis patients with severe renal failure, the dose should not exceed 7.5 mg daily.
The maximum recommended daily dose of MELFION is 15 mg.
As a dosage for use in children has yet to be established, usage of Melfion should be restricted to adults.
Tablet should be swallowed with water or other fluid in conjunction with food.